Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle

Journal of Neural Transmission

Volumn 122, Issue , 2015, Pages 47-54

  Popa Wagner, A ^a,f   Buga, Ana Maria ^a   Popescu, B ^b,c,d   Muresanu, D ^e  

^a Electron Microscopy Center University Medicine   (Germany)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Carol Davila School of Medicine   (Romania)

^d VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^e IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Alzheimer s disease; Glucose consumption; Insulin signaling; Neurovascular unit; Vascular cognitive impairment; Vascular dementia

Indexed keywords

AGING; ALZHEIMER DISEASE; AUTOREGULATION; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN METABOLISM; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; DEMENTIA; ENERGY RESOURCE; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; MULTIINFARCT DEMENTIA; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; REVIEW; BRAIN; CEREBROVASCULAR DISEASE; ENERGY METABOLISM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; BRAIN; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DEMENTIA; ENERGY METABOLISM; HUMANS;

EID: 84938812976     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1129-3     Document Type: Review

References (73)

1. Aichner F, Bauer G (2005) Cerebral anoxia. In: Niedermeyer E, Lopez da Silva F (eds) Electroencephalography: basic principles, clinical applications and related fields, Williams & Wilkins, Baltimore, pp 455–470
2. Baquer NZ, Taha A, Kumar P et al (2009) A metabolic and functional overview of brain aging linked to neurological disorders. Biogerontology 10:377–413
3. Barone FC, Rosenbaum DM, Zhou J et al (2009) Vascular cognitive impairment: dementia biology and translational animal models. Curr Opin Investig Drugs 10:624–637
4. Biagi L, Abbruzzese A, Bianchi MC et al (2007) Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. Magn Reson Imaging 25:696–702
5. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74
6. Breteler MM (2000) Vascular risk factors for Alzheimer’s disease: an epidemiologic perspective. Neurobiol Aging 21:153–160
7. Chen Z, Zhong C (2013) Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 108:21–43
8. Chen W, Novotny EJ, Zhu X, Rothman DL, Shulman RG (1993) Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation. Proc Natl Acad Sci USA 90:9896–9900
9. Chua LM, Lim ML, Chong PR, Hu ZP, Cheung NS, Wong BS (2012) Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice. J Alzheimers Dis 29:783–791
10. Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease? Ageing Res Rev 10:264–273
11. de la Torre JC, Mussivand T (1993) Can disturbed brain microcirculation cause Alzheimer’s disease? Neurol Res 15:146–153
12. den Dunnen WF, Brouwer WH, Bijlard E et al (2008) No disease in the brain of a 115-year-old woman. Neurobiol Aging 29:1127–1132
13. Desmond DW, Moroney JT, Sano M et al (2002) Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33:2254–2260
14. Dugan LL, Kim-Han JS (2006) Hypoxic-ischemic brain injury and oxidative stress. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry: molecular, cellular and medical aspects. Elsevier, AP, pp 559–573
15. Emmanuel Y, Cochlin LE, Tyler DJ, de Jager CA, David Smith A, Clarke K (2013) Human hippocampal energy metabolism is impaired during cognitive activity in a lipid infusion model of insulin resistance. Brain Behav 3:134–144
16. Enciu AM, Constantinescu SN, Popescu LM, Mureşanu DF, Popescu BO (2011) Neurobiology of vascular dementia. J Aging Res 2011:401604
17. Fotuhi M, Hachinski V, Whitehouse PJ (2009) Changing perspectives regarding late-life dementia. Nat Rev Neurol 5:649–658
18. Games D, Buttini M, Kobayashi D, Schenk D, Seubert P (2006) Mice as models: transgenic approaches and Alzheimer’s disease. J Alzheimers Dis 9:133–149
19. Giménez-Llort L, Blázquez G, Cañete T, Johansson B et al (2007) Modeling behavioral and neuronal symptoms of Alzheimer’s disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev 31:125–147
20. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/American stroke association. Stroke 42:2672–713
21. Grau-Olivares M, Arboix A (2009) Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? Expert Rev Neurother 9:1201–1217
22. Hachinski VC, Lassen NA, Marshall J (1974) Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 2:207–210
23. Hachinski V, Iadecola C, Petersen RC et al (2006) National institute of neurological disorders and stroke-Canadian stroke network vascular cognitive impairment harmonization standards. Stroke 37:2220–2241
24. Henneberg N, Hoyer S (1995) Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Arch Gerontol Geriatr 21:63–74
25. Hermann DM, Chopp M (2012) Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol 11:369–380
26. Hoyer S (1991) Abnormalities of glucose metabolism in Alzheimer’s disease. Ann NY Acad Sci 640:53–58
27. Hoyer S (2002) The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm 109:341–360
28. Hoyer S, Lannert H, Latteier E, Meisel T (2004) Relationship between cerebral energy metabolism in parietotemporal cortex and hippocampus and mental activity during aging in rats. J Neural Transm 111:575–589
29. Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci 5:347–360
30. Iadecola C (2010) The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 120:287–296
31. Iadecola C, Gorelick PB (2003) Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke 34:335–337
32. Iadecola C, Nedergaard M (2007) Glial regulation of the cerebral microvasculature. Nat Neurosci 10:1369–1376
33. Itoh Y, Yamada M, Hayakawa M et al (1993) Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 116:135–141
34. Jellinger KA (2002) Vascular-ischemic dementia: an update. J Neural Transm (Suppl) 62:1–23
35. Jellinger KA, Attems J (2010) Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol 119:421–433
36. Jin F, Hagemann N, Schäfer ST et al (2013) SDF-1 restores angiogenesis synergistically with VEGF upon LDL exposure despite CXCR4 internalization and degradation. Cardiovasc Res 100:481–491
37. Kamino K, Orr HT, Payami H et al (1992) Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 51:998–1014
38. Laurent S, Briet M, Boutouyrie P (2009) Large and small artery cross-talk and recent morbidity-mortality trials in hypertension. Hypertension 54:388–392
39. Lehmann M, Ghosh PM, Madison C et al (2013) Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2013-305858
40. Li ZG, Zhang W, Sima AA (2007) Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56:1817–1824
41. Marini C, Totaro R, De Santis F et al (2001) Stroke in young adults in the community-based L’Aquila registry: incidence and prognosis. Stroke 32:52–56
42. Mawuenyega KG, Sigurdson W, Ovod V et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330:1774
43. McNay EC, Ong CT, McCrimmon RJ, Cresswell J, Bogan JS, Sherwin RS (2010) Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 93:546–553
44. Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM (2011) Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol 122:293–311
45. Meyer-Luehmann M, Coomaraswamy J, Bolmont T et al (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781–1784
46. Miravalle L, Tokuda T, Chiarle R et al (2000) Substitutions at codon 22 of Alzheimer’s abeta peptide induce conformational changes and diverse apoptotic effects in human cerebral endothelial cells. J Biol Chem 275:27110–27116
47. Mosconi L, Tsui WH, De Santi S et al (2005) Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64:1860–1867
48. Nagy Z, Esiri MM, Jobst KA et al (1997) The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 56:165–170
49. O’Sullivan M (2008) Leukoaraiosis. Pract Neurol 8:26–38
50. Patil SP, Ballard R, Sanchez S, Osborn J, Santangelo D Jr (2012) ApoE: the link between Alzheimer’s-related glucose hypometabolism and Aβ deposition? Med Hypotheses 78:494–496
51. Paulson OB, Hasselbalch SG, Rostrup E, Knudsen GM, Pelligrino D (2010) Cerebral blood flow response to functional activation. J Cereb Blood Flow Metab 30:2–14
52. Pelligrino DA (2006) Regulation of the cerebral circulation. J Appl Physiol 100:3–4
53. Pluta R, Jolkkonen J, Cuzzocrea S, Pedata F, Cechetto D, Popa-Wagner A (2011) Cognitive impairment with vascular impairment and degeneration. Curr Neurovasc Res. 8:342–350
54. Popa-Wagner A, Schroeder E, Walker LC, Kessler Ch (1998) ß-amyloid precursor protein and Aß peptide immunoreactivity in the rat brain following middle cerebral artery occlusion: effect of age. Stroke 29:2196–2202
55. Popa-Wagner A, Pirici D, Zagrean AM et al (2010) Cerebral circulation: anatomy, distribution and physiopathology, advances in medicine and biology. pp 1–45
56. Price JM, Chi X, Hellermann G, Sutton ET (2001) Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurol Res 23:506–512
57. Rensink AA, de Waal RM, Kremer B et al (2003) Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev 43:207–223
58. Roman GC, Tatemichi TK, Erkinjuntti T et al (1993) Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop. Neurology 43:250–260
59. Sadowski M, Pankiewicz J, Scholtzova H et al (2004) Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. Neuropathol Exp Neurol 63:418–428
60. Schneider JA, Bennett D (2010) Where vascular and neurodegenerative diseases meet. Stroke 41(10 Suppl):S144–S146
61. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 62:1148–1155
62. Selnes OA, Vinters HV (2006) Vascular cognitive impairment. Nat Clin Pract Neurol 2:538–534
63. Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain. Brain Res Brain Res Rev 33:199–227
64. Takeda S, Sato N, Rakugi H, Morishita R (2011) Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. Mol BioSyst 7:1822–1827
65. Talbot K, Wang HY, Kazi H et al (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316–1338
66. Thal DR, Ghebremedhin E, Orantes M et al (2003) Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62:1287–1301
67. van Beek AH, Claassen JA, Rikkert MG, Jansen RW (2008) Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab 28:1071–1085
68. Vinters HV, Ellis WG, Zarow C et al (2000) Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59:931–945
69. Vlassenko AG, Vaishnavi SN, Couture L et al (2010) Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proc Natl Acad Sci USA 107:17763–17767
70. Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol 118:87–102
71. Wolburg H, Noell S, Mack A et al (2009) Brain endothelial cells and the glio-vascular complex. Cell Tissue Res 335:75–96
72. Zechariah A, ElAli A, Hagemann N, Jin F, Doeppner TR, Helfrich I, Mies G, Hermann DM (2013) Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells. Arterioscler Thromb Vasc Biol 33:1561–1567
73. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178–201